How to prevent children from accidental e-liquid exposures
July 5th 2023To combat instances of e-liquid exposure and accidental ingestions among children, the FDA is offering tips for best storage and safety practices for those that regularly use and handle these products, according to a recent press release.
CAP-1002 demonstrates positive phase 2 results to treat Duchenne muscular dystrophy
June 30th 2023Improvement in the left ventricular ejection fraction (LVEF) and statistically significant benefit in the Performance of the Upper Limb (PUL v2.0) scale were observed following 2 years of CAP-1002 treatment in Duchenne muscular dystrophy (DMD) patients.
FDA accepts NDA for givinostat to treat Duchenne muscular dystrophy
June 29th 2023According to Italfarmaco Group, a New Drug Application (NDA) for givinostat has been accepted and granted priority review by the FDA to treat Duchenne muscular dystrophy (DMD) patients, following positive topline phase 3 trial results.
FDA approves somatrogon-ghla to treat pediatric growth hormone deficiency
June 28th 2023Indicated for growth hormone deficiency (GHD) patients aged 3 years and older, somatrogon-ghla is now FDA-approved to treat GHD following positive phase 3 data demonstrating non-inferiority, measured by annual height velocity at 12 months, compared to somatropin.
Prevalence of bariatric surgery among adolescents and teenagers with obesity
June 27th 2023Nicole Peña Sahdala, MD, internist, gastroenterologist specialist in bariatric endoscopy, ABIM certified, discusses the rise in bariatric surgery among youth, and why other forms of care, such as lifestyle changes and education, are essential before any surgery is performed.
How pediatricians can support patients exposed to intimate partner violence
June 26th 2023About 1 in 4 children are exposed to intimate partner violence (IPV) in their lifetime, according to the American Academy of Pediatrics. The AAP has released tips and recommendations for pediatricians to help support these patients and their families.
FDA clears Owlet’s pulse oximetry sock for infants
June 23rd 2023After Owlet’s baby-monitoring Smart Sock was pulled from the market in 2021, the FDA has cleared the company’s BabySat pulse oximetry sock for infants, capable of monitoring and alerting parents of pulse rate and oxygen saturation levels.
Discussing the importance of lipid screenings in the pediatric population
June 21st 2023In this Contemporary Pediatrics® interview, Dave Little, MD, MS, Physician Informaticist at Epic, discusses the importance of lipid screening in the pediatric population, specifically for children aged 9 to 11 years and those aged 2 to 8 years with increased risk of diabetes, obesity, or high blood pressure. Little says awareness of lipid screenings at the provider and parent levels can lead to more screenings overall, which can lead to healthier lifestyles for children.
FDA approves empagliflozin, empagliflozin plus metformin for pediatric type 2 diabetes
June 21st 2023Children 10 years and older with type 2 diabetes (T2D) can now be treated with empagliflozin and empagliflozin plus metformin hydrochloride to improve blood sugar control, per a recent approval by the FDA.
Children with ASD respond well to a family-centered procedural sedation protocol
June 20th 2023A family-centered procedural sedation protocol for children with autism spectrum disorder (ASD) or developmental delay (DD) allowed 93% of patients to be free of restraints during routine health care procedures.
How do parents handle their child’s belly pain?
June 20th 2023Based on results from a recent C.S. Mott Children’s Hospital National Poll on Children’s Health, find out how comfortable parents feel when it comes to abdominal pain in their child, and how likely they are to handle the issue themselves, or to reach out to a health care provider for help.